T2 Biosystems Announces Submission for FDA Breakthrough Device Designation for T2Biothreat Panel
T2 Biosystems Announces Submission for FDA Breakthrough Device Designation for T2Biothreat Panel – read this article along with other careers information, tips and advice on BioSpace…
Read the full article at: www.biospace.com
Continue Reading »R2 Technologies Reaches First Year Commercial Milestone of Shipping 100 GLACIAL® Devices
R2 Technologies Reaches First Year Commercial Milestone of Shipping 100 GLACIAL® Devices – read this article along with other careers information, tips and advice on BioSpace…
Read the full article at: www.biospace.com
Continue Reading »Still looking to trim the fat, Acutus sells line of heart devices to Medtronic for $50M upfront
If there’s a name for the much less exciting inverse of a shopping spree, Acutus Medical is on it.
Read the full article at: www.fiercebiotech.com
Continue Reading »Covestro Debuts Sustainable Proof-of-Concept Drug Delivery Device
The sustainable demo product by Covestro highlights the company’s medical-grade polycarbonates.
Read the full article at: www.mddionline.com
Continue Reading »FDA Considers New Approach to Improve Safe Disposal of Prescription Opioid Analgesics, Decrease Unnecessary Exposure to Unused Medication | FDA
The U.S Food and Drug Administration established a public docket to consider adding a mail-back envelope requirement to the Opioid Analgesic Risk Evaluation and Mitigation Strategy to require that all opioid analgesics, including immediate-release, extended-release, and long-acting formulations, …
Read the full article at: www.fda.gov
Continue Reading »FDA ramps up cybersecurity efforts with stricter guidance for devicemakers
Important things come on a quadrennial basis: leap years, presidential elections, the Olympics and, apparently, edicts from the FDA about the need for heightened cybersecurity measures to protect c…
Read the full article at: www.fiercebiotech.com
Continue Reading »Abbott picks up the pace with FDA approval of removable, long-lasting leadless pacemaker
Though the FDA approval for Abbott’s first leadless pacemaker comes several years after its competitor Medtronic achieved the feat, the devicemaker is aiming to up the tempo.
Read the full article at: www.fiercebiotech.com
Continue Reading »FDA doubles down on push for ‘innovative’ disposable duodenoscopes to cut contamination
The FDA has spent the better part of the last decade examining the contamination risk of reusable, reprocessed duodenoscopes—and, based on those findings,…
Read the full article at: www.fiercebiotech.com
Continue Reading »vMap Mapping Technology for Cardiac Arrhythmias: Interview with Mike Monko, CEO of Vektor Medical | Medgadget
Vektor Medical, a medtech company based in San Diego, created the vMap system, a mapping solution for cardiac arrhythmias. The system is the first to identify arrhythmia sources anywhere in the heart, including the septal wall, outflow tracts, and all four chambers.
Read the full article at: www.medgadget.com
Continue Reading »Fluent BioSciences Wins $1.7M SBIR Grant from NIH to Commercialize Single-Cell Tech
The Watertown, Massachusetts-based firm will use the funds to commercialize PIPseq, a single-cell partitioning method that can be done in a PCR tube.
Read the full article at: www.genomeweb.com
Continue Reading »